Cf foundation invests up to $9 million in arcturus therapeutics to develop a messenger rna therapy

Bethesda, md.--(business wire)--the cystic fibrosis foundation is providing additional funding to arcturus therapeutics to develop an inhaled messenger rna therapy for cf.

ARCT Ratings Summary

ARCT Quant Ranking